Inflammatory bowel disease is highly prevalent around several regions of the world and often affects the quality of life among patients. The growing prevalence of inflammatory bowel disease has compelled healthcare experts around the world to aggressively work toward the discovery of effective and in-vitro inflammatory bowel disease diagnostics due to which, the global in-vitro inflammatory bowel disease diagnostics market has witnessed considerable movement over the past few years. In-vitro inflammatory bowel disease diagnostics primarily relies on endoscopy– an invasive procedure wherein anesthesia and bowel preparation is required. Although endoscopy has largely remained a go-to medical procedure, the negative effect on the patient’s quality of life continues to remain a major challenge.
In the wake of these existing challenges, a range of new technologies and advancements, including in-vitro inflammatory bowel disease diagnostics is currently gaining considerable adoption. The recent advancements in positron emission tomography (PET), especially with the use of antibody-conjugated tracers, have offered promising results, while treating inflammatory bowel disease, a factor that is expected to propel the growth of the global in-vitro inflammatory bowel disease diagnostics market during the assessment period.
To know the scope of our report Get a Sample on In-vitro Inflammatory Bowel Disease Diagnostic Test Market
Due to the growing prevalence of inflammatory bowel diseases, novel biologics are steadily being developed across laboratories and hitting clinics around the world. As players involved in the current in-vitro inflammatory bowel disease diagnostics market landscape are increasingly focusing on gaining approval of the FDA, the race toward discovering the most efficient and cost-effective in-vitro inflammatory bowel disease diagnostics continues to shift gears. In addition, as healthcare providers are increasingly emphasizing on improving the overall well-being of the patient, with it, efforts to improve in-vitro inflammatory bowel disease diagnostics continue to grow at a rapid pace. Research and development activities are projected to play a key role in the overall growth of the global in-vitro inflammatory bowel disease diagnostics market during the assessment period. At the moment, researchers around the world are increasingly leveraging high throughput in-vitro assays to discover the most effective compounds. The safety, longevity, and overall effectiveness of these compounds are being tested to minimize the prevalence of inflammatory bowel diseases.
Get a glimpse of the in-depth analysis through our Report Brochure
While researchers continue to take steps to improve the efficacy of in-vitro inflammatory bowel disease diagnostics, scientists are also focusing on minimizing research expenses.
The growing prevalence of Crohn’s disease (CD) and ulcerative colitis (UC) in several regions of the world has played a key role in boosting the adoption of biomarkers and analyzers, which, in turn, is expected to propel the growth of the global in-vitro inflammatory bowel disease diagnostics market during the assessment period. The demand for predictive biomarkers has witnessed consistent growth as the need to efficiently assess the mucosal disease activity in inflammatory bowel diseases has become imperative. Serum-based biomarkers have gained considerable traction across the global in-vitro inflammatory bowel disease diagnostics market in recent times and as per current observations, this trend is likely to provide a considerable push to the growth of the market for in-vitro inflammatory bowel disease diagnostics.
The healthcare sector has arguable remained one of the busiest core sectors during the ongoing COVID-19 pandemic, as researchers, scientists, and other stakeholders in the healthcare sector are increasingly focusing on discovering vaccines to contain the novel coronavirus. The progress in in-vitro inflammatory bowel disease diagnostics has remained relative slower. Although research and development activities are expected to continue during the ongoing pandemic, the adoption of in-vitro inflammatory bowel disease diagnostics is expected to remain sluggish, particularly in 2020 due to the fear among patients pertaining to contracting the novel coronavirus in hospitals.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global in-vitro inflammatory bowel disease diagnostics market is expected to expand at a CAGR of ~4% during the forecast period. The market growth can be attributed to factors, including growing prevalence of inflammatory bowel diseases around the world, research and development activities, technological advancements, growing interest and adoption of minimally invasive procedures, and increasing emphasis on improving patient well-being. While the market growth will remain slower than initial projections in 2020 due to the ongoing COVID-19 pandemic, the market is expected to show signs of recovery during the last quarter of 2020.
In-vitro Inflammatory Bowel Disease Diagnostic Market – Segmentation
TMR’s study on the global in-vitro inflammatory bowel disease diagnostic market includes information divided into three segments: product, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global in-vitro inflammatory bowel disease diagnostic market have been discussed in detail.
Product |
|
End User |
|
Region |
|
In-vitro inflammatory bowel disease diagnostic market was worth US$ 1.5 Bn and is projected to reach a value of US$ 2.3 Bn by the end of 2030
In-vitro inflammatory bowel disease diagnostic market is anticipated to grow at a CAGR of 4% during the forecast period 2020 - 2030
In-vitro inflammatory bowel disease diagnostic market is driven by growing prevalence of inflammatory bowel diseases around the world, research and development activities, technological advancements, and growing interest and adoption of minimally invasive procedures
The assays/biomarker segment dominated the global in-vitro inflammatory bowel disease diagnostic market and the trend is likely to continue during the forecast period
Key players in the global in-vitro inflammatory bowel disease diagnostic market include DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL., and Biosystems S.A.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In-vitro Inflammatory Bowel Disease Diagnostic Market
4. Market Overview
4.1. Introduction & Overview
4.2. Product Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Developments
5.3. Fecal Biomarkers – Advancement
6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
6.2.1. Assays/Biomarker
6.2.1.1. Calprotectin
6.2.1.2. Lactoferrin
6.2.1.3. Bile Acids
6.2.1.4. H. pylori SA
6.2.1.5. Pancreatic Elastase
6.2.1.6. Others
6.2.2. Analyzers
6.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Product
7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$) Forecast, by End-user, 2018–2030
7.2.1. Diagnostic Laboratories
7.2.2. Hospitals
7.2.3. Research Institutes
7.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by End-user
8. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Region
9. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
9.1. Introduction
9.2. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
9.2.1. Assays/Biomarker
9.2.1.1. Calprotectin
9.2.1.2. Lactoferrin
9.2.1.3. Bile Acids
9.2.1.4. H. pylori SA
9.2.1.5. Pancreatic Elastase
9.2.1.6. Others
9.2.2. Analyzers
9.3. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
9.3.1. Diagnostic Laboratories
9.3.2. Hospitals
9.3.3. Research Institutes
9.4. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
10.1. Introduction
10.2. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Assays/Biomarker
10.2.1.1. Calprotectin
10.2.1.2. Lactoferrin
10.2.1.3. Bile Acids
10.2.1.4. H. pylori SA
10.2.1.5. Pancreatic Elastase
10.2.1.6. Others
10.2.2. Analyzers
10.3. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.3.3. Research Institutes
10.4. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.2.1. Assays/Biomarker
11.2.1.1. Calprotectin
11.2.1.2. Lactoferrin
11.2.1.3. Bile Acids
11.2.1.4. H. pylori SA
11.2.1.5. Pancreatic Elastase
11.2.1.6. Others
11.2.2. Analyzers
11.3. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
11.3.1. Diagnostic Laboratories
11.3.2. Hospitals
11.3.3. Research Institutes
11.4. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
12.1. Introduction
12.2. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.2.1. Assays/Biomarker
12.2.1.1. Calprotectin
12.2.1.2. Lactoferrin
12.2.1.3. Bile Acids
12.2.1.4. H. pylori SA
12.2.1.5. Pancreatic Elastase
12.2.1.6. Others
12.2.2. Analyzers
12.3. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
12.3.1. Diagnostic Laboratories
12.3.2. Hospitals
12.3.3. Research Institutes
12.4. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
13.2.1. Assays/Biomarker
13.2.1.1. Calprotectin
13.2.1.2. Lactoferrin
13.2.1.3. Bile Acids
13.2.1.4. H. pylori SA
13.2.1.5. Pancreatic Elastase
13.2.1.6. Others
13.2.2. Analyzers
13.3. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
13.3.1. Diagnostic Laboratories
13.3.2. Hospitals
13.3.3. Research Institutes
13.4. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Position Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. DiaSorin S.p.A
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Company Financials
14.2.1.3. Growth Strategies
14.2.1.4. SWOT Analysis
14.2.2. F. Hoffmann-La Roche Ltd
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Company Financials
14.2.2.3. Growth Strategies
14.2.2.4. SWOT Analysis
14.2.3. Siemens Healthineers AG
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Company Financials
14.2.3.3. Growth Strategies
14.2.3.4. SWOT Analysis
14.2.4. Abbott
14.2.4.1. Company Overview (HQ, Business Segments)
14.2.4.2. Company Financials
14.2.4.3. Growth Strategies
14.2.4.4. SWOT Analysis
14.2.5. Quidel Corporation
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Company Financials
14.2.5.3. Growth Strategies
14.2.5.4. SWOT Analysis
14.2.6. BÜHLMANN Laboratories AG
14.2.6.1. Company Overview (HQ, Business Segments)
14.2.6.2. Growth Strategies
14.2.6.3. SWOT Analysis
14.2.7. American Laboratory Products Company (ALPCO)
14.2.7.1. Company Overview (HQ, Business Segments)
14.2.7.2. Growth Strategies
14.2.7.3. SWOT Analysis
14.2.8. Certest Biotec SL
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Growth Strategies
14.2.8.3. SWOT Analysis
14.2.9. Biosystems S.A.
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Growth Strategies
14.2.9.3. SWOT Analysis
List of Tables
Table 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 07: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030
Table 08: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 09: Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 10: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 11: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 12: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 15: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 16: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 19: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 20: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 21: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030
Table 24: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Product, 2019
Figure 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by End-user, 2019
Figure 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Region, 2019
Figure 05: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 06: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Assays/Biomarkers, 2018–2030
Figure 07: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Analyzers, 2018–2030
Figure 08: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 09: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 10: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Diagnostic Laboratories, 2018–2030
Figure 11: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Hospitals, 2018–2030
Figure 12: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Research Institutes, 2018–2030
Figure 13: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 14: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Region, 2019 and 2030
Figure 15: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Analysis, by Region
Figure 16: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 17: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country, 2019 and 2030
Figure 18: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country, 2020–2030
Figure 19: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030
Figure 20: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030
Figure 21: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 22: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user2020–2030
Figure 23: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 24: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 25: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 26: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030
Figure 27: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030
Figure 28: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 29: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 30: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 31: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 32: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 33: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030
Figure 34: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030
Figure 35: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 36: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 37: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 38: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 39: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 40: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030
Figure 41: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030
Figure 42: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 43: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user 2020–2030
Figure 44: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 45: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 46: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 47: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030
Figure 48: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030
Figure 49: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 50: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user 2020–2030
Figure 51: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Analysis, by Top Company Ranking, 2019